Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Autor: Alva AS; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Halabi S; Duke University Medical Center, Durham, NC., Hansra D; Cancer Treatment Centers of America, Atlanta, GA., Calfa CJ; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Khalil MF; Lehigh Valley Cancer Institute, Allentown, PA., Ahn ER; Cancer Treatment Centers of America, Chicago, IL., Cannon TL; Inova Schar Cancer Institute, Fairfax, VA., Crilley P; Cancer Treatment Centers of America, Philadelphia, PA., Fisher JG; Levine Cancer Institute, Atrium Health, Charlotte, NC., Haslem DS; Intermountain Logan Cancer Clinic, Logan, UT., Shrestha S; Cancer Treatment Centers of America, Tulsa, OK., Antonelli KR; American Society of Clinical Oncology, Alexandria, VA., Butler NL; American Society of Clinical Oncology, Alexandria, VA., Warren SL; American Society of Clinical Oncology, Alexandria, VA., Rygiel AL; American Society of Clinical Oncology, Alexandria, VA., Ranasinghe S; American Society of Clinical Oncology, Alexandria, VA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Aug 01; Vol. 39 (22), pp. 2443-2451. Date of Electronic Publication: 2021 Apr 12.

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Autor: Fisher JG; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Tait D; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Garrett-Mayer E; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Halabi S; Duke University Medical Center, Durham, NC, USA., Mangat PK; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA. TAPURPublications@asco.org., Schink JC; Cancer Treatment Centers of America, Chicago, IL, USA., Alvarez RH; Cancer Treatment Centers of America, Atlanta, GA, USA., Veljovich D; Swedish Cancer Institute, Seattle, WA, USA., Cannon TL; Inova Schar Cancer Institute, Fairfax, VA, USA., Crilley PA; Cancer Treatment Centers of America, Philadelphia, PA, USA., Pollock T; Cancer Treatment Centers of America, Tulsa, OK, USA., Calfa CJ; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Al Baghdadi T; Michigan Cancer Research Consortium, Ypsilanti, MI, USA., Thota R; Intermountain Precision Genomics Cancer Clinic, Salt Lake City, UT, USA., Fleming N; The University of Texas MD Anderson Cancer Center, Sugarland, TX, USA., Cotta JA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Rygiel AL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Warren SL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA., Schilsky RL; American Society of Clinical Oncology, 2318 Mill Road, Alexandria, VA, 22314, USA.

Publikováno v: Targeted oncology [Target Oncol] 2020 Dec; Vol. 15 (6), pp. 733-741.

Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Autor: Al Baghdadi T; Michigan Cancer Research Consortium, Ypsilanti, MI., Halabi S; Duke University Medical Center, Durham, NC., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Mangat PK; American Society of Clinical Oncology, Alexandria, VA., Ahn ER; Cancer Treatment Centers of America, Chicago, IL., Sahai V; University of Michigan Rogel Cancer Center, Ann Arbor, MI., Alvarez RH; Cancer Treatment Centers of America, Atlanta, GA., Kim ES; Levine Cancer Institute, Atrium Health, Charlotte, NC., Yost KJ; Cancer Research Consortium of West Michigan, Grand Rapids, MI., Rygiel AL; American Society of Clinical Oncology, Alexandria, VA., Antonelli KR; American Society of Clinical Oncology, Alexandria, VA., Butler NL; American Society of Clinical Oncology, Alexandria, VA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2019 Dec; Vol. 3, pp. 1-8.